The Vertical Group — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Route 92route92medical.comin𝕏Nov 2023 · $31M✓ verified
Route 92 Medical develops medical devices and procedural solutions for patients undergoing neurovascular intervention.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Chou(Founder, Chief Executive Officer)Dr. Joey English(Chief Medical Officer)
Co-investorsNovo HoldingsUS Venture PartnersNorwest Venture PartnersSectoral Asset ManagementU.S. Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.